illumina各测序试剂盒接头序列引物序列信息2014年度8月.pdfVIP

Confidential Illumina, Inc. 5200 Illumina Way San Diego, CA 92122 U.S.A. 1.858.202.4500 1.858.202.4545 (fax) August 12, 2014 Dear Customer, We are providing this letter in response to your request for nucleotide sequence information about oligonucleotides used in Illumina sequencing technologies. As explained below, this letter and its contents are provided to you so you may understand and publish the results of your sequencing experiments. Most Illumina oligonucleotides are specially modified and purified in a proprietary manner to enable and optimize their performance with Illumina instruments. The oligonucleotides described in this letter are available directly from Illumina, which is the only authorized supplier of the oligos. Illumina has no control over the quality, composition, or compatibility of reagents from non-authorized suppliers. We cannot troubleshoot or provide other support for experiments performed with non-authorized reagents, and we cannot guarantee the performance of Illumina products when used with such reagents. The oligonucleotides described in this letter are proprietary to Illumina, and their manufacture, use, and sequence information are protected by intellectual property, including issued or pending patents, copyright, and trade secrets. Illumina reserves all rights in the oligonucleotides and their sequence information, except for the strictly limited permissions as follows. Limited permission to copy or distribute sequence information You are permitted to copy and distribute this letter within your institution, but only for use with Illumina instruments (including the Genome Analyzer™, HiSeq®, HiScan®, and MiSeq® instruments) and their associated equipment, reagents, kits, and software (“Illumina products”). You may not copy or distribute this letter or its information outside your institution, or where it will be